Form 8.3 SPIRE HEALTHCARE GROUP PLC

Summary by AI BETAClose X

Barclays disclosed on 11 Nov 2026 a Form 8.3 showing direct interests of 7,020,624 Spire Healthcare shares (1.74%) and short positions of 6,443,586 shares (1.60%), cash-settled derivatives of 6,444,708 shares (1.60%) long and 7,052,452 shares (1.75%) short, with no stock-settled derivatives; total long exposure is 13,465,332 shares (3.34%) versus total short exposure of 13,496,038 shares (3.35%), a net short of 30,706 shares (~0.01%), and Barclays executed market purchases and sales on 10 Nov 2026 at approximately £2.475–£2.485 per share.

Disclaimer*

UK 100

Latest directors dealings